全球牙科膜和移植骨替代物市场规模（按膜类型、移植骨替代物类型、最终用户、地区、范围和预测）

牙科膜和移植骨替代物市场规模和预测

2024 年牙科膜和移植骨替代物市场规模价值 20.7 亿美元，预计到 2032 年将达到 39.7 亿美元，2026 年至 2032 年的复合年增长率为 8.46%。

牙膜和移植骨替代物是用于人工植牙手术的材料，用于促进骨再生和组织修復。牙膜用于覆盖和保护骨移植，并确保其与周围骨骼良好融合。骨移植是当骨骼密度不足以支撑植入时，用于替代或补充天然骨的材料。这些替代物可以是合成的、源自其他动物的，也可以是人体组织製成的。它们在引导骨再生和窦增高术等手术中至关重要，有助于恢復失去的骨结构并促进新骨形成。

随着材料科学的进步，以及牙科问题和美容手术日益增多带来的牙科植入需求的不断增长，牙科膜和移植骨替代物市场预计将迅速扩张。生物材料的创新，例如生物活性和可吸收膜及移植物的研发，预计将提升这些产品的有效性。

它与干细胞疗法和组织工程等再生医学方法的结合可能会拓宽其应用范围。人口老化和人们对口腔健康的认识不断提高预计将推动市场的扩张，并为新的和改进的牙科再生解决方案开闢前景。

全球牙科膜和移植骨替代物市场动态

关键市场驱动因素

牙科疾病和牙齿脱落发病率不断上升：市场成长主要受牙科疾病和牙齿脱落发病率不断上升的驱动。根据世界卫生组织 (WHO) 的数据，全球约有 35 亿人患有口腔疾病，其中最常见的是未治疗的恆牙龋齿（蛀牙），影响 23 亿人。

老龄人口不断增长：老年人口的增长增加了对牙膜和骨移植的需求，因为他们面临更大的牙齿问题和牙齿脱落的风险。根据联合国经济和社会事务部的数据，到2050年，全球每六人中就有一人年龄超过65岁（占总人口的16%），而2019年这一比例为每十一人中就有一人（占总人口的9%）。

牙科旅游日益流行，尤其是在较贫穷的国家，这导致对现代牙科护理的需求不断增长。根据「无国界患者」（Patients Beyond Borders）组织的数据，牙科旅游市场规模预计在2021年达到58.3亿美元，2022年至2030年的复合年增长率为12.1%。

主要挑战

法规合规性：确保跨地区的法规合规性是一项重要任务。牙科膜和骨移植必须符合美国药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等卫生机构制定的严格要求。满足这些要求需要进行大量的测试和记录，这既耗时又耗费成本。各国监管标准的差异可能会使国际市场准入变得复杂，并增加违规的风险，从而延迟产品上市并限制市场准入。

患者个别差异：患者健康状况、骨质和癒合反应的个别差异都会影响人工植牙治疗的成功率。患者反应的差异使得生产通用有效的牙膜和骨移植替代品变得困难。开发满足不同患者需求的产品需要进一步研究和客製化，这使得产品开发更加复杂且成本高昂。

临床证据有限：新型牙科膜或骨移植的有效性必须有强而有力的临床证据支持。临床数据不足或不确定可能会阻碍产品的采用和市场认可。确保产品已通过广泛且充分的临床试验证明其安全有效。缺乏强有力的临床数据也可能导致牙科相关人员的不信任，从而损害产品的可信度。

主要趋势：

生物分解性材料：人们对开发生物分解性的牙科膜和骨移植替代材料的兴趣日益浓厚。这些材料旨在随着时间的推移自然分解并被人体吸收，无需手术切除，并减少潜在的副作用。生物分解性的解决方案可提高患者的舒适度，同时降低长期副作用的风险。材料科学的发展正在推动开发更有效、更安全的生物分解性解决方案，从而支持致力于改善患者治疗效果和加快牙科手术速度的行业。

3D列印技术：3D列印技术正在改变牙科膜和移植骨替代物市场，因为它能够製造高度客製化和精准的产品。该技术能够创建具有复杂特征的患者专用植入和移植物，精确匹配患者的解剖学要求。它还支援快速原型製作和新材料的开发。根据个人需求客製化产品的能力提高了牙科治疗的有效性，并拓展了移植骨替代物在再生牙科领域的潜在应用。

更重视以病人为中心的照护：牙科护理领域日益重视以病人为中心的服务，这推动了牙科膜和骨移植替代品的发展。这一趋势凸显了开发不仅能改善治疗效果，还能提升患者整体体验的产品的必要性。舒适性、易用性和缩短恢復时间在产品开发中变得越来越重要。透过满足这些患者需求，公司希望开发出更有效、更方便患者的解决方案。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. 牙科膜和移植骨替代物市场（按膜类型）

• 可吸收膜
• 不可吸收膜

5. 牙科膜和移植骨替代物市场（按骨移植类型）

• 同种异体移植
• 异质骨移植
• 合成移植物
• 自体移植

6. 牙科膜和移植骨替代物市场（按最终用户）

• 医院
• 门诊手术中心
• 牙医诊所

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Geistlich Pharma AG
• Straumann Group（Switzerland）Ltd
• Medtronic
• Danaher Corporation
• Zimmer Biomet Holdings, Inc
• Illeris AG
• Botiss Biomaterials GmbH
• Osteogenics Biomedical Inc
• BioHorizons Corp
• CR Bard, Inc
• 11. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities

第十二章 附录

• 简称列表
• 来源和参考文献

Dental Membrane And Bone Graft Substitutes Market Size And Forecast

Dental Membrane And Bone Graft Substitutes Market size was valued at USD 2.07 Billion in 2024 and is projected to reach USD 3.97 Billion by 2032, growing at a CAGR of 8.46% from 2026 to 2032.

Dental membranes and bone graft substitutes are materials used in dental implant operations to promote bone regeneration and tissue repair. Dental membranes are utilized to cover and protect bone grafts, ensuring that they integrate well into the surrounding bone. Bone graft substitutes are materials that replace or supplement natural bone in locations where bone density is insufficient to support implant insertion. These alternatives may be synthetic, obtained from other animals, or processed from human tissue. They are essential in operations like guided bone regeneration and sinus augmentation, which help restore lost bone structure and promote new bone formation.

The dental membrane and bone graft replacements market is predicted to expand rapidly because of advances in materials science and increased demand for dental implants, which is being driven by the increasing prevalence of dental problems and cosmetic operations. biomaterial innovations, such as the creation of bioactive and resorbable membranes and grafts, are expected to improve the efficacy of these products.

The combination of regenerative medicine approaches, such as stem cell therapy and tissue engineering, could broaden their applicability. The aging population and growing awareness of oral health are expected to fuel market expansion, opening up prospects for new and improved dental regeneration solutions.

Global Dental Membrane And Bone Graft Substitutes Market Dynamics

The key market dynamics that are shaping the global dental membrane and bone graft substitutes market include:

Key Market Drivers:

Increasing Prevalence of Dental Diseases and Tooth Loss: The market is primarily driven by the rising frequency of dental diseases and tooth loss. According to the World Health Organization (WHO), almost 3.5 billion people worldwide suffer from oral disorders, with untreated dental caries (tooth decay) in permanent teeth being the most prevalent, impacting 2.3 billion people.

Rising Geriatric Population: The growing older population increases the need for dental membranes and bone graft substitutes due to the increased risk of dental problems and tooth loss. According to the United Nations Department of Economic and Social Affairs, by 2050, one in every six individuals worldwide will be beyond the age of 65 (16% of the population), up from one in every eleven in 2019 (9%).

Growing Dental Tourism: Dental tourism is growing in popularity, especially in poorer countries, leading to increased demand for modern dental procedures. According to Patients Beyond Borders, the dental tourism business is predicted to be valued at USD 5.83 Billion in 2021, with an annual growth rate of 12.1% between 2022 and 2030.

Key Challenges:

Regulatory Compliance: Ensuring regulatory compliance across several regions presents a substantial problem. Dental membranes and bone graft substitutes must adhere to strict requirements established by health authorities such as the FDA in the United States and the EMA in Europe. Navigating these requirements necessitates considerable testing and documentation, which may be expensive and time-consuming. Discrepancies in regulatory standards between nations can complicate international market entry and raise the risk of non-compliance, thereby delaying product introductions and limiting market access.

Patient Variability: Individual variances in patients' overall health, bone quality, and healing responses can all have an impact on the success of dental implant treatments. Variability in patient responses makes it difficult to produce universally effective dental membranes and bone graft alternatives. Tailoring items to meet various patient needs necessitates additional research and customization, which complicates product development and raises expenses.

Limited Clinical Evidence: The effectiveness of novel dental membranes and bone graft substitutes must be backed up by strong clinical evidence. Insufficient or inconclusive clinical data can impede product adoption and market acceptance. Ensure that goods have a demonstrated track record of safety and efficacy through extensive and well-documented clinical trials. The lack of strong clinical data can also cause distrust among dental professionals and undermine product credibility.

Key Trends:

Biodegradable Materials: There is a rising interest in developing biodegradable dental membranes and bone transplant alternatives. These materials are intended to spontaneously degrade and be absorbed by the body over time, eliminating the need for surgical removal and limiting potential consequences. Biodegradable solutions increase patient comfort while lowering the risk of long-term side effects. Advances in materials science are enabling the development of more effective and safe biodegradable solutions, which supports the industry's emphasis on improving patient outcomes and expediting dental procedures.

3D Printing Technology: 3D printing technology is transforming the dental membrane and bone graft substitute markets by allowing for the fabrication of highly customized and precise goods. This technology enables the creation of patient-specific implants and grafts with complicated features that precisely match the patient's anatomical requirements. It also enables rapid prototyping and development of novel materials. The capacity to personalize goods to individual needs improves the efficacy of dental treatments and broadens the possible uses of bone graft substitutes in regenerative dentistry.

Increasing Focus on Patient-Centric Care: There is a growing emphasis on patient-centered service in dentistry, which is driving the development of dental membranes and bone graft alternatives. This trend highlights the need to create products that not only improve therapeutic outcomes but also the total patient experience. Comfort, simplicity of use, and shortened recuperation time are increasingly important aspects of product development. By addressing these patient needs, businesses hope to develop more effective and patient-friendly solutions.

Global Dental Membrane And Bone Graft Substitutes Market Regional Analysis

Here is a more detailed regional analysis of the global dental membrane and bone graft substitutes market:

North America:

North America dominates the dental membrane and bone graft substitutes market, owing to its advanced healthcare infrastructure and increased awareness of oral health. The region's high prevalence of dental disorders, with over 26% of adults in the United States suffering from untreated tooth decay and around 46% exhibiting indicators of gum disease, highlights the need for improved dental therapies. The growing older population, which is expected to nearly double from 52 million in 2018 to 95 million by 2060, is especially vulnerable to oral problems, increasing demand for dental membranes and bone graft operations. The growing use of dental implants, with 3 million Americans already having implants and 500,000 new cases each year, strongly correlates with the need for these dental materials, which are required for successful implant surgeries.

Significant investments in dental R&D also drive market expansion. For instance, the National Institute of Dental and Craniofacial Research (NIDCR) obtained a budget of USD 501.23 Million for fiscal year 2022, a large increase over previous years. This investment is expected to drive advances in dental materials and methods, such as dental membranes and bone transplant alternatives. These factors-high prevalence of dental disorders, an aging population, increasing dental implant operations, and significant R&D investment-are projected to keep North America's dominant position in the global dental membrane and bone graft substitutes market.

Asia Pacific:

The Asia Pacific region is emerging as the fastest-growing market for dental membrane and bone graft alternatives, owing to increased urbanization, rising disposable incomes, and heightened awareness of oral health and aesthetic dentistry. The WHO has highlighted the high prevalence of dental illnesses, which has a huge impact on this region, with countries such as India having dental caries prevalence in adults of up to 82.4%. The prevalence of oral diseases is driving demand for improved dental treatments. Furthermore, the growing dental tourism business in Thailand, India, and Malaysia is driving up demand for high-quality dental operations, such as dental membranes and bone transplant alternatives.

The region's rising senior population, which is expected to more than double from 535 million in 2015 to 1.3 billion by 2050, is especially vulnerable to periodontal diseases and tooth loss, necessitating the use of innovative dental solutions. Increased government investments in dental health, such as India's National Oral Health Programme, are improving oral health infrastructure and raising awareness, further encouraging the use of modern treatments. These combined factors are likely to accelerate the Asia Pacific dental membrane and bone graft substitutes market, potentially making it the world's fastest-growing region.

Global Dental Membrane And Bone Graft Substitutes Market: Segmentation Analysis

The Global Dental Membrane And Bone Graft Substitutes Market is Segmented on the basis of Type of Membrane, Type of Bone Graft Substitute, End-User, And Geography.

Dental Membrane And Bone Graft Substitutes Market, By Type of Membrane

• Resorbable Membranes
• Non-resorbable Membranes

Based on Type of Membrane, the market is fragmented into Resorbable Membranes and Non-resorbable Membranes. Resorbable membranes now dominate the dental membrane and bone graft substitutes market due to their ability to eliminate the requirement for a second surgical treatment to remove the membrane. These membranes are often comprised of biocompatible materials that deteriorate slowly over time, making the treatment procedure easier for patients. Non-resorbable membranes are rapidly expanding because to their higher mechanical strength and capacity to maintain a stable barrier over an extended length of time, facilitating optimal bone regeneration. While they require a second surgery to remove, advances in material science and surgical procedures are reducing this disadvantage, adding to their growing popularity.

Dental Membrane And Bone Graft Substitutes Market, By Type of Bone Graft Substitute

• Allografts
• Xenografts
• Synthetic Grafts
• Autografts

Based on Type of Bone Graft Substitute, the market is segmented into Allografts, Xenografts, Synthetic Grafts, and Autografts. Autografts now lead the dental membrane and bone graft substitutes market because of their better osteoconductive and osteoinductive qualities, which promote optimal bone regeneration. However, the intrusive aspect of collecting bone from a patient's own body frequently causes donor site morbidity, limiting its broad use. Synthetic grafts are emerging as the most rapidly developing segment. These grafts provide various benefits, including uniform quality, a lower risk of disease transmission, and convenience of use. Ongoing breakthroughs in material science are resulting in the creation of synthetic grafts with higher biocompatibility and osteoconductive qualities, which is driving market expansion.

Dental Membrane And Bone Graft Substitutes Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Dental Clinics

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Dental Clinics. Dental clinics is dominating the dental membrane and bone graft substitutes market owing to their extensive availability, emphasis on oral healthcare, and established patient relationships. Ambulatory surgery clinics are rapidly expanding because they provide specialized equipment and experience for difficult dental treatments including bone grafting and membrane insertion. The growing need for minimally invasive and efficient treatments is driving patients to ambulatory surgery facilities, which is contributing to their market growth.

Dental Membrane And Bone Graft Substitutes Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Dental Membrane And Bone Graft Substitutes Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the dental membrane and bone graft substitutes market, owing to its advanced healthcare infrastructure, large geriatric population, and high acceptance rates of advanced dental procedures. Asia Pacific, on the other hand, is the fastest-growing region, owing to rapid urbanization, increased disposable income, expanding dental tourism, and heightened awareness of oral health.

Key Players

The "Global Dental Membrane And Bone Graft Substitutes Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Geistlich Pharma AG, Straumann Group (Switzerland) Ltd, Medtronic, Danaher Corporation, Zimmer Biomet Holdings, Inc., Illeris AG, Botiss Biomaterials GmbH, Osteogenics Biomedical, Inc., BioHorizons Corp, and C.R. Bard, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Dental Membrane And Bone Graft Substitutes Market Recent Developments
• In October 2023, ZimVie, Inc., a worldwide life sciences business, introduced the Biotivity A/C Plus Membrane in the United States. This barrier membrane contains growth factors that help in jaw restoration and implant stability. This move increases ZimVie's position in dental biomaterials, with an emphasis on wound healing enhancement.
• In May 2022, BONESUPPORT AB, an orthobiologics business, stated that Cerament G had been granted market authorization by the United States Food and Drug Administration. It is the first and only bone graft substitute intended to fill gaps during surgical operations and treat bone abnormalities.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Dental Membrane And Bone Graft Substitutes Market, By Type of Membrane

• Resorbable Membranes
• Non-resorbable Membranes

5.Dental Membrane And Bone Graft Substitutes Market, By Type of Bone Graft Substitute

• Allografts
• Xenografts
• Synthetic Grafts
• Autografts

6.Dental Membrane And Bone Graft Substitutes Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Dental Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Geistlich Pharma AG
• Straumann Group (Switzerland) Ltd
• Medtronic
• Danaher Corporation
• Zimmer Biomet Holdings, Inc
• Illeris AG
• Botiss Biomaterials GmbH
• Osteogenics Biomedical Inc
• BioHorizons Corp
• C.R. Bard, Inc
• 11. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References